Paper658148
Evidence for an endogenous factor interfering with 3H-diazepam binding to rat brain membranes.
Karobath M and 2 others. Eur J Pharmacol, 1978. Cited by 58 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Evidence for an endogenous factor interfering with 3H-diazepam binding to rat brain membranes. Papers, record 658148. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/658148
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evidence for an endogenous factor interfering with 3H-diazepam binding to rat brain membranes.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Products | Major topic |
| Brain | Major topic |
| Diazepam | Major topic |
| Tissue Extracts | Major topic |
| Animals | |
| Cattle | |
| Humans | |
| In Vitro Techniques | |
| Membranes | |
| Mice | |
| Organ Specificity | |
| Rats |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,784,145 | The benzodiazepines and inosine antagonize caffeine-induced seizures. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6784145 | PubMed |
| 6,304,714 | Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6304714 | PubMed |
| 6,275,442 | Anticonvulsant doses of inosine result in brain levels sufficient to inhibit [3H] diazepam binding. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6275442 | PubMed |
| 6,246,535 | Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6246535 | PubMed |
| 3,023,548 | Purification and characterization of tribulin, and endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor binding. | J Neural Transm | 1986 | https://conductscience.org/library/papers/3023548 | PubMed |
| 3,014,522 | Isolation and identification in bovine cerebral cortex of n-butyl beta-carboline-3-carboxylate, a potent benzodiazepine binding inhibitor. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3014522 | PubMed |
| 286,337 | Inosine, an endogenous ligand of the brain benzodiazepine receptor, antagonizes pentylenetetrazole-evoked seizures. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/286337 | PubMed |
| 284,422 | Identification of inosine and hypoxanthine as endogenous ligands for the brain benzodiazepine-binding sites. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/284422 | PubMed |
| 284,378 | Stimulation of benzodiazepine receptor binding by gamma-aminobutyric acid. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/284378 | PubMed |
| 32,539 | Competitive inhibition of benzodiazepine binding by fractions from porcine brain. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/32539 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/658148
GET https://conductscience.org/api/papers/v1/658148/authors